- Home
- AVIR vs GDEV Comparison
AVIR vs GDEV Comparison
Compare AVIR & GDEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVIR | GDEV |
|---|---|---|
| Founded | 2012 | 2009 |
| Country | United States | Cyprus |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 266.4M | 308.9M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | AVIR | GDEV |
|---|---|---|
| Price | $3.61 | $15.00 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 397.2K | 2.9K |
| Earning Date | 11-12-2025 | 11-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 50.98 |
| EPS | N/A | ★ 3.08 |
| Revenue | N/A | ★ $412,018,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.89 |
| P/E Ratio | ★ N/A | $4.87 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.46 | $8.60 |
| 52 Week High | $4.02 | $42.20 |
Technical Indicators
Market Signals| Indicator | AVIR | GDEV |
|---|---|---|
| Relative Strength Index (RSI) | 64.59 | 41.13 |
| Support Level | $3.34 | $14.86 |
| Resistance Level | $3.63 | $15.70 |
| Average True Range (ATR) | 0.15 | 0.51 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 86.18 | 25.58 |
Price Performance
Historical ComparisonAbout AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About GDEV GDEV Inc.
GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.